Label-Free Technologies for Drug Discovery

Author:   Matthew Cooper, 195 (Institute for Molecular Bioscience, University of Queensland, Australia) ,  Lorenz M Mayr (Biology Unit, Protease Platform, Novartis Pharma AG, Basel, Switzerland)
Publisher:   John Wiley & Sons
ISBN:  

9786613373960


Pages:   352
Publication Date:   31 January 2011
Format:   Electronic book text
Availability:   In stock   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $538.56 Quantity:  
Add to Cart

Share |

Label-Free Technologies for Drug Discovery


Add your own review!

Overview

Over the past two decades the benefits of label-free biosensor analysis have begun to make an impact in the market, and systems are beginning to be used as mainstream research tools in many drug discovery laboratories.

Label-Free Technologies For Drug Discovery summarises the latest and emerging developments in label-free detection systems, their underlying technology principles and end-user case studies that reveal the power and limitations of label-free in all areas of drug discovery.

Label-free technologies discussed include SPR, NMR, high-throughput mass spectrometry, resonant waveguide plate-based screening, transmitted-light imaging, isothermal titration calorimetry, optical and impedance cell-based assays and other biophysical methods. The technologies are discussed in relation to their use as screening technologies, high-content technologies, hit finding and hit validation strategies, mode of action and ADME/T, access to difficult target classes, cell-based receptor/ligand interactions particularly orphan receptors, and antibody and small molecule affinity and kinetic analysis.

Label-Free Technologies For Drug Discovery is an essential guide to this emerging class of tools for researchers in drug discovery and development, particularly high-throughput screening and compound profiling teams, medicinal chemists, structural biologists, assay developers, ADME/T specialists, and others interested in biomolecular interaction analysis.

Full Product Details

Author:   Matthew Cooper, 195 (Institute for Molecular Bioscience, University of Queensland, Australia) ,  Lorenz M Mayr (Biology Unit, Protease Platform, Novartis Pharma AG, Basel, Switzerland)
Publisher:   John Wiley & Sons
Imprint:   John Wiley & Sons
ISBN:  

9786613373960


ISBN 10:   6613373966
Pages:   352
Publication Date:   31 January 2011
Audience:   General/trade ,  General
Format:   Electronic book text
Publisher's Status:   Active
Availability:   In stock   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

lgn

al

Shopping Cart
Your cart is empty
Shopping cart
Mailing List